Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
Benign Prostatic Hyperplasia (BPH)
Related content
Benign Prostatic Hyperplasia (BPH)
The Prostate Microbiome Is Associated With Prostate Size and PSA Level, Independent of Age, in BPH Patients
Prostate
Sun A, Rodriguez-Alvarez JS, Harper S, Khooblall P, Dang T, De S, Miller AW
doi: 10.1002/pros.24891
Uro-Oncology
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study
Eur Urol
Saad F, Hussain MHA, Tombal B, Fizazi K, Sternberg CN, Crawford ED, Nordquist LT, Bögemann M, Tutrone R, Shore ND, Belkoff L, Fralich T, Jhaveri J, Srinivasan S, Li R, Verholen F, Kuss I, Smith MR
doi: 10.1016/j.eururo.2024.03.036
COMMENTED
Uro-Oncology
Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
JAMA Oncol
Tilki D, Chen MH, Wu J, Huland H, Graefen M, Trock BJ, Han M, D'Amico AV
doi: 10.1001/jamaoncol.2025.0110
Benign Prostatic Hyperplasia (BPH)
Single-port transvesical simple prostatectomy for the surgical treatment of benign prostatic hyperplasia: functional and continence outcomes
Prostate Cancer Prostatic Dis
Pacini M, Lambertini L, Avesani G, Torres Anguiano JR, Morgantini L, Martin A, Sauer Calvo R, Haberal HB, Bignante G, Minervini A, Zucchi A, Bartoletti R, Crivellaro S
doi: 10.1038/s41391-024-00923-y
Uro-Oncology
Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial
J Urol
Bahler CD, Tachibana I, Tann M, Collins K, Swensson JK, Green MA, Mathias CJ, Tong Y, Yong C, Boris RS, Brocken E, Hutchins GD, Sims JB, Hill DV, Smith N, Ferari C, Love H, Koch MO
doi: 10.1097/JU.0000000000004032
Benign Prostatic Hyperplasia (BPH)
Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review
Prostate
Abid A, Piperdi H, Babar M, Loloi J, Moutwakil A, Azhar U, Maria P, Small A
doi: 10.1002/pros.24717
Further Publications Urology
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy
BJU Int
Merseburger AS, Agarwal N, Bjartell A, Uemura H, Soto AJ, Bhaumik A, Böhm J, Tran N, Krochmann N, Nematian-Samani M, Mundle SD, Brookman-May SD, Lopez-Gitlitz A, McCarthy SA, Chi K, Chowdhury S
doi: 10.1111/bju.16449
Uro-Oncology
PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer
Eur Urol
Englman C, Maffei D, Allen C, Kirkham A, Albertsen P, Kasivisvanathan V, Baroni RH, Briganti A, De Visschere P, Dickinson L, Gómez Rivas J, Haider MA, Kesch C, Loeb S, Macura KJ, Margolis D, Mitra AM, Padhani AR, Panebianco V, Pinto PA, Ploussard G, Puech P, Purysko AS, Radtke JP, Rannikko A, Rastinehad A, Renard-Penna R, Sanguedolce F, Schimmöller L, Schoots IG, Shariat SF, Schieda N, Tempany CM, Turkbey B, Valerio M, Villers A, Walz J, Barrett T, Giganti F, Moore CM
doi: 10.1016/j.eururo.2024.03.014
Benign Prostatic Hyperplasia (BPH)
Transperineal laser ablation in the management of benign prostatic hyperplasia: an updated systematic review and pooled analysis
Prostate Cancer Prostatic Dis
Alberti A, Lo Re M, Nicoletti R, Polverino P, Cadenar A, Ciaralli E, Solazzi F, Giustozzi B, Sessa F, Rivetti A, Campi R, Sebastianelli A, Serni S, Gacci M
doi: 10.1038/s41391-025-00952-1